Combined angiotensin-converting enzyme inhibition and receptor blockade associate with increased risk of cardiovascular death in hemodialysis patients. [electronic resource]
Producer: 20120206Description: 978-985 p. digitalISSN:- 1523-1755
- Analysis of Variance
- Angiotensin II Type 1 Receptor Blockers -- adverse effects
- Angiotensin-Converting Enzyme Inhibitors -- adverse effects
- Antihypertensive Agents -- adverse effects
- Cardiovascular Diseases -- etiology
- Drug Therapy, Combination
- Female
- Humans
- Hypertension -- complications
- Kaplan-Meier Estimate
- Kidney Failure, Chronic -- complications
- Logistic Models
- Male
- Middle Aged
- Propensity Score
- Proportional Hazards Models
- Renal Dialysis -- mortality
- Retrospective Studies
- Risk Assessment
- Risk Factors
- Survival Rate
- Time Factors
- Treatment Outcome
- United States -- epidemiology
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.